Your teeth are whispering secrets about your health! Have you heard them? It's time that you listen to them before you fall ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...

The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, ...

The best-selling author and podcaster on how to preserve robust physical, cognitive and emotional health, and how Medicine ...

Rejuvenating the brain's lymphatic vessels can enhance memory in aging mice by improving the removal of waste products from ...

Rodabe Amaria, MD, discusses the current role of OBX-115 for the treatment of patients with checkpoint inhibitor-resistant metastatic melanoma.

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Learn how ultrafine bubble showers can improve eczema symptoms by reducing inflammation and enhancing skin barrier proteins.

As aging bodies decline, the brain loses the ability to cleanse itself of waste, a scenario that scientists think could be ...

US pharma major Johnson & Johnson (NYSE: JNJ) has won US approval for Tremfya (guselkumab) in the treatment of adults with ...

RedCloud and Marwynn Holdings have recently made their public debuts. The operator of a B2B platform for sellers of consumer goods in emerging ...